Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Thiamine pyrophosphate (TPP), also known as thiamine diphosphate or cocarboxylase, is the active coenzyme form of vitamin B1 (thiamine). It is formed in the body by phosphorylation of thiamine and serves as an essential cofactor for several enzymes involved in carbohydrate metabolism, including pyruvate dehydrogenase and transketolase. TPP plays a critical role in decarboxylation reactions and the pentose phosphate pathway. Deficiency leads to impaired energy metabolism and neurological symptoms. Thiamine pyrophosphate is not typically administered directly as a drug; instead, thiamine or its salts are given, which are then converted to TPP in vivo[3][8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on thiamine pyrophosphate.